Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
126 hedge funds and large institutions have $472M invested in Flexion Therapeutics, Inc. in 2019 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 45 increasing their positions, 30 reducing their positions, and 18 closing their positions.
178% more call options, than puts
Call options by funds: $7.03M | Put options by funds: $2.53M
50% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 30
16% more capital invested
Capital invested by funds: $407M → $472M (+$65.6M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less funds holding
Funds holding: 129 → 126 (-3)
17% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$10.5M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$5.36M |
| 3 |
MVP
Miller Value Partners
Sarasota,
Florida
|
+$4.31M |
| 4 |
BlackRock
New York
|
+$2.73M |
| 5 |
RA
Royce & Associates
New York
|
+$2.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
-$6.7M |
| 2 |
State Street
Boston,
Massachusetts
|
-$4.05M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$4.04M |
| 4 |
CC
Carlson Capital
Dallas,
Texas
|
-$3.31M |
| 5 |
CC
Clearline Capital
New York
|
-$1.34M |
FLXN Hedge Fund Activity: Q3 2019 in Review
126 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q3 2019, worth a combined $472M — up 16% from $407M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of FLXN and 15 opened new positions — a net loss of 3 holders — while 30 trimmed existing stakes and 45 added.
The largest buyer was Wasatch Advisors, adding an estimated $10.5M. The largest seller was Schroder Investment Management Group, cutting an estimated $6.7M.
- 126 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q3 2019, down from 129 in Q2 2019.
- Funds reported $472M of Flexion Therapeutics, Inc. stock for Q3 2019, up 16% quarter-over-quarter.
- 15 funds opened new Flexion Therapeutics, Inc. positions in Q3 2019 and 18 closed out, a net change of -3 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q3 2019 was Wasatch Advisors, an estimated $10.5M added.
- The largest Flexion Therapeutics, Inc. seller in Q3 2019 was Schroder Investment Management Group, an estimated $6.7M sold.
Based on aggregated 13F filings for Q3 2019.